AU3922601A - A radiopharmaceutical for radionuclide tumor therapy - Google Patents
A radiopharmaceutical for radionuclide tumor therapyInfo
- Publication number
- AU3922601A AU3922601A AU39226/01A AU3922601A AU3922601A AU 3922601 A AU3922601 A AU 3922601A AU 39226/01 A AU39226/01 A AU 39226/01A AU 3922601 A AU3922601 A AU 3922601A AU 3922601 A AU3922601 A AU 3922601A
- Authority
- AU
- Australia
- Prior art keywords
- radiopharmaceutical
- tumor therapy
- radionuclide tumor
- radionuclide
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200293 | 2000-01-28 | ||
EP00200293 | 2000-01-28 | ||
PCT/EP2001/000714 WO2001054734A2 (en) | 2000-01-28 | 2001-01-23 | 188re-labelled 5-thio-d-glucose for radionucleotide tumor therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3922601A true AU3922601A (en) | 2001-08-07 |
Family
ID=8170952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU39226/01A Abandoned AU3922601A (en) | 2000-01-28 | 2001-01-23 | A radiopharmaceutical for radionuclide tumor therapy |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3922601A (en) |
WO (1) | WO2001054734A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100430061B1 (en) * | 2000-03-21 | 2004-05-03 | 재단법인 아산사회복지재단 | Radioisotope labeled complex of glucose derivatives and kit for preparation thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ335950A (en) * | 1996-12-18 | 2000-06-23 | Nihon Mediphysics Co Ltd | Radioactive transition metal nitride hetero-complex |
WO1999020316A1 (en) * | 1997-10-20 | 1999-04-29 | Board Of Regents, The University Of Texas System | Single photon-emitting radiotraces and methods for their use |
-
2001
- 2001-01-23 WO PCT/EP2001/000714 patent/WO2001054734A2/en active Application Filing
- 2001-01-23 AU AU39226/01A patent/AU3922601A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001054734A3 (en) | 2001-12-06 |
WO2001054734A2 (en) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001237827A1 (en) | Radioactive therapeutic liposomes | |
GB0023983D0 (en) | Therapeutic compounds | |
GB2367472B (en) | Radiation therapy planning | |
GB0016681D0 (en) | Therapeutic compounds | |
GB9930570D0 (en) | Therapy | |
GB0028583D0 (en) | Therapeutic compounds | |
GB9907243D0 (en) | Therapy | |
GB9900222D0 (en) | Therapeutic compounds | |
AUPR320701A0 (en) | The new cancer therapeutic agent with a thiopeptides | |
EP1242064A4 (en) | Liver selective therapy | |
AU3922601A (en) | A radiopharmaceutical for radionuclide tumor therapy | |
AU2001268744A1 (en) | Characterizing a brain tumor | |
HK1041455A1 (en) | A cancer thermotherapy | |
AU3567500A (en) | Photodynamic therapy compounds | |
GB0013105D0 (en) | Therapeutic compounds | |
AUPR036500A0 (en) | Tumour radiotherapy | |
AUPR773101A0 (en) | Multiple targeted radionuclide therapy for cancer | |
GB0015215D0 (en) | Tumour therapy | |
GB9908804D0 (en) | Radiotherapy | |
GB9913084D0 (en) | Tumour therapy | |
SI1296722T1 (en) | Radiotherapy | |
AU2002259248A1 (en) | Radioactive therapeutic seeds | |
AUPR743101A0 (en) | A cancer therapeutic | |
GB9916886D0 (en) | Therapeutic compounds | |
GB9921718D0 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |